News

Studies expand potential of ZFN-mediated genome editing as a therapeutic modality.

Synergy Pharmaceuticals, Inc. announced that it has filed a lawsuit in New York State Supreme Court against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie.

The European commission has appointed Anne Glover as its first ever chief scientific adviser.

The approach offers an innovative scientific approach for designing optimized protein formulations, and reduces the need for extensive stability testing.

In this article, researchers from Leibniz University Hannover report the multistep flow synthesis of vinyl azides and their application in the synthesis of vinyltriazoles.

As President of the company’s Ethanol Division Mark Beemer will be responsible for the development, deployment and execution of the ethanol water separation business for North America.

The study reported overall response rate of 66% in patients with relapsed or refractory chronic lymphocytic leukemia, with 12% of patients achieving complete response. After a median follow-up of 31 months, overall survival Was 75%.

Detection of epigenetic changes could provide better diagnosis and disease management as MDxHealth’s Prostate ConfirmMDxTM test helps identify men with suspected prostate cancer, thus avoiding unnecessary repeat biopsies.

Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.

OriginOil, Inc., the developer of a new technology to extract oil from algae, has announced the funding of a new research agreement with the Department of Energy’s Idaho National Laboratory (INL).